HUN
Huntsman Corporation
Chemicals
Market Cap$2.56B
5Y Perf.-18.8%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
HUN vs DOW vs LYB vs EMN vs CC
Revenue, margins, valuation, and 5-year total return — side by side.
DOW
Dow Inc.
Chemicals
Market Cap$26.86B
5Y Perf.-3.3%
LYB
LyondellBasell Industries N.V.
Chemicals - Specialty
Market Cap$23.04B
5Y Perf.+12.1%
EMN
Eastman Chemical Company
Chemicals - Specialty
Market Cap$8.43B
5Y Perf.+8.2%
CC
The Chemours Company
Chemicals - Specialty
Market Cap$3.36B
5Y Perf.+70.9%
HUN vs DOW vs LYB vs EMN vs CC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | HUN | DOW | LYB | EMN | CC |
|---|---|---|---|---|---|
| Industry | Chemicals | Chemicals | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $2.56B | $26.86B | $23.04B | $8.43B | $3.36B |
| Revenue (TTM) | $5.69B | $39.33B | $22.48B | $8.64B | $5.82B |
| Net Income (TTM) | $-324M | $-2.76B | $-774M | $399M | $-411M |
| Gross Margin | 12.9% | 6.2% | -19.3% | 19.8% | 15.1% |
| Operating Margin | -1.0% | -2.3% | -0.9% | 9.4% | -0.8% |
| Forward P/E | — | 12.6x | 9.9x | 12.5x | 15.5x |
| Total Debt | $2.73B | $19.60B | $15.96B | $5.08B | $4.58B |
| Cash & Equiv. | $429M | $3.82B | $3.45B | $566M | $672M |
HUN vs DOW vs LYB vs EMN vs CC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
HUN
DOW
LYB
EMN
CC
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Huntsman Corporation (HUN) | 100 | 81.2 | -18.8% |
| Dow Inc. (DOW) | 100 | 96.7 | -3.3% |
| LyondellBasell Indu… (LYB) | 100 | 112.1 | +12.1% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
| The Chemours Company (CC) | 100 | 170.9 | +70.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HUN vs DOW vs LYB vs EMN vs CC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: LYB leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Eastman Chemical Company is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. CC also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
HUN
Huntsman Corporation
The Growth Play
HUN is the clearest fit if your priority is growth exposure.
- Rev growth -5.8%, EPS growth -44.5%, 3Y rev CAGR -10.9%
Best for: growth exposure
DOW
Dow Inc.
The Defensive Pick
DOW is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.76, current ratio 1.97x
Best for: sleep-well-at-night
LYB
LyondellBasell Industries N.V.
The Income Pick
LYB carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 2 yrs, beta 0.38, yield 7.7%
- Beta 0.38, yield 7.7%, current ratio 1.77x
- Lower P/E (9.9x vs 15.5x)
- Beta 0.38 vs CC's 1.92, lower leverage
Best for: income & stability and defensive
EMN
Eastman Chemical Company
The Quality Compounder
EMN is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 4.6% margin vs CC's -7.1%
- 2.6% ROA vs CC's -5.5%, ROIC 6.7% vs -0.1%
Best for: quality and efficiency
CC
The Chemours Company
The Long-Run Compounder
CC ranks third and is worth considering specifically for long-term compounding.
- 219.7% 10Y total return vs LYB's 48.6%
- 0.4% revenue growth vs LYB's -25.2%
- +108.8% vs EMN's +2.3%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CC | 0.4% revenue growth vs LYB's -25.2% |
| Value | LYB | Lower P/E (9.9x vs 15.5x) |
| Quality / Margins | EMN | 4.6% margin vs CC's -7.1% |
| Stability / Safety | LYB | Beta 0.38 vs CC's 1.92, lower leverage |
| Dividends | LYB | 7.7% yield, 2-year raise streak, vs EMN's 4.5% |
| Momentum (1Y) | CC | +108.8% vs EMN's +2.3% |
| Efficiency (ROA) | EMN | 2.6% ROA vs CC's -5.5%, ROIC 6.7% vs -0.1% |
HUN vs DOW vs LYB vs EMN vs CC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
HUN vs DOW vs LYB vs EMN vs CC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLEMNLAGGINGLYB
Who Leads Where
EMN leads in 2 of 6 categories
CC leads 1 • HUN leads 0 • DOW leads 0 • LYB leads 0 • 3 tied
Explore the data ↓LYBLyondellBasell Indust…
0leads
DOWDow Inc.
0leads
HUNHuntsman Corporation
0leads
CCThe Chemours Company
1leads
EMNEastman Chemical Comp…
2leads
6 Total Categories
CATEGORYLEADERvs CCvs HUNMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
EMN4/6
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
EMN7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CC3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
EMN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DOW is the larger business by revenue, generating $39.3B annually — 6.9x HUN's $5.7B. EMN is the more profitable business, keeping 4.6% of every revenue dollar as net income compared to CC's -7.1%. On growth, CC holds the edge at +1.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | HUNHuntsman Corporat… | DOWDow Inc. | LYBLyondellBasell In… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5.7B | $39.3B | $22.5B | $8.6B | $5.8B |
| EBITDAEarnings before interest/tax | $160M | $1.3B | $865M | $1.2B | -$132M |
| Net IncomeAfter-tax profit | -$324M | -$2.8B | -$774M | $399M | -$411M |
| Free Cash FlowCash after capex | $135M | -$2.0B | $3.1B | $498M | $198M |
| Gross MarginGross profit ÷ Revenue | +12.9% | +6.2% | -19.3% | +19.8% | +15.1% |
| Operating MarginEBIT ÷ Revenue | -1.0% | -2.3% | -0.9% | +9.4% | -0.8% |
| Net MarginNet income ÷ Revenue | -5.7% | -7.0% | -3.4% | +4.6% | -7.1% |
| FCF MarginFCF ÷ Revenue | +2.4% | -5.1% | +13.6% | +5.8% | +3.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.7% | -6.1% | -100.0% | -4.9% | +1.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.3% | -68.2% | -100.0% | -40.8% | -6.1% |
EMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
Evenly matched — HUN and LYB and EMN each lead in 2 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than LYB's 33.4x.
| Metric | HUNHuntsman Corporat… | DOWDow Inc. | LYBLyondellBasell In… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| Market CapShares × price | $2.6B | $26.9B | $23.0B | $8.4B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $4.9B | $42.6B | $35.5B | $12.9B | $7.3B |
| Trailing P/EPrice ÷ TTM EPS | -9.27x | -10.11x | -30.43x | 17.97x | -8.75x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.62x | 9.92x | 12.50x | 15.55x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 5.59x | — |
| EV / EBITDAEnterprise value multiple | 19.64x | 13.78x | 33.44x | 8.96x | 21.72x |
| Price / SalesMarket cap ÷ Revenue | 0.45x | 0.67x | 0.76x | 0.96x | 0.58x |
| Price / BookPrice ÷ Book value/share | 0.86x | 1.52x | 2.26x | 1.41x | 13.44x |
| Price / FCFMarket cap ÷ FCF | 22.11x | — | 59.99x | 19.87x | 65.93x |
Evenly matched — HUN and LYB and EMN each lead in 2 of 6 comparable metrics.
Profitability & Efficiency
EMN leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-163 for CC. EMN carries lower financial leverage with a 0.84x debt-to-equity ratio, signaling a more conservative balance sheet compared to CC's 18.27x. On the Piotroski fundamental quality scale (0–9), EMN scores 5/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | HUNHuntsman Corporat… | DOWDow Inc. | LYBLyondellBasell In… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.1% | -15.4% | -7.2% | +6.7% | -163.4% |
| ROA (TTM)Return on assets | -4.6% | -4.6% | -3.0% | +2.6% | -5.5% |
| ROICReturn on invested capital | -0.6% | +0.6% | -1.1% | +6.7% | -0.1% |
| ROCEReturn on capital employed | -0.7% | +0.5% | -1.1% | +7.5% | -0.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 | 3 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.92x | 1.12x | 1.56x | 0.84x | 18.27x |
| Net DebtTotal debt minus cash | $2.3B | $15.8B | $12.5B | $4.5B | $3.9B |
| Cash & Equiv.Liquid assets | $429M | $3.8B | $3.4B | $566M | $672M |
| Total DebtShort + long-term debt | $2.7B | $19.6B | $16.0B | $5.1B | $4.6B |
| Interest CoverageEBIT ÷ Interest expense | -1.08x | -1.51x | -1.42x | 2.22x | 1.15x |
EMN leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LYB five years ago would be worth $8,867 today (with dividends reinvested), compared to $6,018 for HUN. Over the past 12 months, CC leads with a +108.8% total return vs EMN's +2.3%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs HUN's -12.6% — a key indicator of consistent wealth creation.
| Metric | HUNHuntsman Corporat… | DOWDow Inc. | LYBLyondellBasell In… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +45.5% | +55.2% | +62.6% | +15.8% | +83.6% |
| 1-Year ReturnPast 12 months | +37.5% | +37.3% | +37.2% | +2.3% | +108.8% |
| 3-Year ReturnCumulative with dividends | -33.3% | -17.5% | -5.5% | +3.4% | -15.7% |
| 5-Year ReturnCumulative with dividends | -39.8% | -27.2% | -11.3% | -28.4% | -22.7% |
| 10-Year ReturnCumulative with dividends | +57.6% | +12.2% | +48.6% | +35.4% | +219.7% |
| CAGR (3Y)Annualised 3-year return | -12.6% | -6.2% | -1.9% | +1.1% | -5.5% |
CC leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — HUN and LYB each lead in 1 of 2 comparable metrics.
Risk & Volatility
LYB is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than CC's 1.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUN currently trades 92.7% from its 52-week high vs CC's 78.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | HUNHuntsman Corporat… | DOWDow Inc. | LYBLyondellBasell In… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.73x | 0.76x | 0.38x | 1.36x | 1.92x |
| 52-Week HighHighest price in past year | $15.89 | $42.74 | $83.94 | $84.18 | $28.67 |
| 52-Week LowLowest price in past year | $7.30 | $20.40 | $41.58 | $56.11 | $9.13 |
| % of 52W HighCurrent price vs 52-week peak | +92.7% | +87.3% | +85.2% | +87.5% | +78.1% |
| RSI (14)Momentum oscillator 0–100 | 65.4 | 48.9 | 50.9 | 56.9 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 6.2M | 14.4M | 8.1M | 1.5M | 3.1M |
Evenly matched — HUN and LYB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — LYB and EMN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HUN as "Hold", DOW as "Hold", LYB as "Hold", EMN as "Buy", CC as "Hold". Consensus price targets imply 6.0% upside for DOW (target: $40) vs -18.6% for HUN (target: $12). For income investors, LYB offers the higher dividend yield at 7.66% vs CC's 2.31%.
| Metric | HUNHuntsman Corporat… | DOWDow Inc. | LYBLyondellBasell In… | EMNEastman Chemical … | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $12.00 | $39.55 | $73.60 | $77.29 | $22.14 |
| # AnalystsCovering analysts | 33 | 35 | 39 | 35 | 20 |
| Dividend YieldAnnual dividend ÷ price | +5.7% | +5.6% | +7.7% | +4.5% | +2.3% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 2 | 12 | 0 |
| Dividend / ShareAnnual DPS | $0.85 | $2.09 | $5.48 | $3.30 | $0.52 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +0.9% | +1.2% | 0.0% |
Evenly matched — LYB and EMN each lead in 1 of 2 comparable metrics.
Key Takeaway
EMN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CC leads in 1 (Total Returns). 3 tied.
Best OverallEastman Chemical Company (EMN)Leads 2 of 6 categories
Loading custom metrics...
HUN vs DOW vs LYB vs EMN vs CC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HUN or DOW or LYB or EMN or CC a better buy right now?
For growth investors, The Chemours Company (CC) is the stronger pick with 0.
4% revenue growth year-over-year, versus -25. 2% for LyondellBasell Industries N. V. (LYB). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Eastman Chemical Company (EMN) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HUN or DOW or LYB or EMN or CC?
On forward P/E, LyondellBasell Industries N.
V. is actually cheaper at 9. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HUN or DOW or LYB or EMN or CC?
Over the past 5 years, LyondellBasell Industries N.
V. (LYB) delivered a total return of -11. 3%, compared to -39. 8% for Huntsman Corporation (HUN). Over 10 years, the gap is even starker: CC returned +219. 7% versus DOW's +12. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HUN or DOW or LYB or EMN or CC?
By beta (market sensitivity over 5 years), LyondellBasell Industries N.
V. (LYB) is the lower-risk stock at 0. 38β versus The Chemours Company's 1. 92β — meaning CC is approximately 403% more volatile than LYB relative to the S&P 500. On balance sheet safety, Eastman Chemical Company (EMN) carries a lower debt/equity ratio of 84% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.
05Which is growing faster — HUN or DOW or LYB or EMN or CC?
By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.
4% versus -25. 2% for LyondellBasell Industries N. V. (LYB). On earnings-per-share growth, the picture is similar: Huntsman Corporation grew EPS -44. 5% year-over-year, compared to -549. 1% for The Chemours Company. Over a 3-year CAGR, CC leads at -5. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HUN or DOW or LYB or EMN or CC?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -6. 6% for The Chemours Company — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 1% for LYB. At the gross margin level — before operating expenses — EMN leads at 21. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HUN or DOW or LYB or EMN or CC more undervalued right now?
On forward earnings alone, LyondellBasell Industries N.
V. (LYB) trades at 9. 9x forward P/E versus 15. 5x for The Chemours Company — 5. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DOW: 6. 0% to $39. 55.
08Which pays a better dividend — HUN or DOW or LYB or EMN or CC?
All stocks in this comparison pay dividends.
LyondellBasell Industries N. V. (LYB) offers the highest yield at 7. 7%, versus 2. 3% for The Chemours Company (CC).
09Is HUN or DOW or LYB or EMN or CC better for a retirement portfolio?
For long-horizon retirement investors, LyondellBasell Industries N.
V. (LYB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), 7. 7% yield). The Chemours Company (CC) carries a higher beta of 1. 92 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LYB: +48. 6%, CC: +219. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HUN and DOW and LYB and EMN and CC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HUN is a small-cap income-oriented stock; DOW is a mid-cap income-oriented stock; LYB is a mid-cap income-oriented stock; EMN is a small-cap deep-value stock; CC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(HUN: 0.7% · DOW: -6.1%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.